Summary of Key Points from the Conference Call Company Overview - The company discussed its performance for 2025 and provided guidance for 2026, indicating a strong growth trajectory in various business segments, particularly in the chemical macromolecule and emerging business sectors [2][3][16]. Financial Performance - In 2025, the company achieved a revenue of 6.67 billion yuan, a year-on-year increase of 14.9%, aligning with the growth guidance of 13%-15% [3][16]. - The adjusted net profit for 2025 was 1.253 billion yuan, reflecting a growth of over 50% compared to 2024 [3][16]. - The gross profit margin for 2025 was stable at 42%, with a net profit margin of 17%, up by 0.6 percentage points [3][16]. Order Backlog and Growth - As of Q1 2026, the company had an order backlog of 1.385 billion USD, a 31.7% increase year-on-year, driven primarily by the macromolecule business [2][3][16]. - The fourth quarter of 2025 saw a significant increase in orders, marking the highest growth rate in five quarters, attributed to new business orders [2][20]. Business Segment Performance Small Molecule Business - Revenue for the small molecule segment in 2025 was 4.735 billion yuan, a 3.6% increase, with a gross margin of 46.8% [4][6]. - The company is involved in five GLP-1 clinical projects, with two in late-stage development [6][20]. Emerging Business - The emerging business segment generated 1.929 billion yuan in revenue, a 57.3% increase, with a gross margin of 30.1%, up 8 percentage points from 2024 [4][6]. - Revenue from overseas markets in this segment grew by 240% [4][6]. Chemical Macromolecule Business - This segment saw a revenue increase of 123% to 1.028 billion yuan, with a backlog growth of 127.6% [4][6]. - The company is servicing 19 GLP-1 clinical projects, with eight in late-stage development [6][15]. Biopharmaceutical CDMO - The biopharmaceutical CDMO business nearly doubled its revenue to 294 million yuan, with a 55.6% increase in order backlog [9][10]. - The first ADC commercial workshop is expected to be delivered in Q2 2026 [10]. Capital Expenditure and Capacity Expansion - The company plans to invest 2.1 billion yuan in capital expenditures for 2026, with 70%-80% directed towards new business segments [2][19]. - The production capacity for solid-phase peptide synthesis is expected to expand to 69,000 liters by the end of 2026 [2][19]. Market Trends and Challenges - The company noted that the recent Middle East conflict has led to price increases in raw materials, but the overall impact on costs is manageable [17][18]. - There is a growing demand for new modalities in the CDMO market, particularly in conjugated drugs and peptides, indicating a positive outlook for future orders [21][22]. Outlook for 2026 - The company expects revenue growth of 19%-22% for 2026, with an additional 2-3 percentage points expected from constant currency adjustments [2][16]. - The gross margin for the emerging business is anticipated to improve further due to increased overseas revenue and enhanced delivery capabilities [18][22]. Conclusion - The company is well-positioned for continued growth across its various business segments, with a strong order backlog and strategic investments planned for capacity expansion and new business development [2][3][16][19].

Core Insights - The article discusses the concept of AI Virtual Cells (AIVC), which are advanced digital systems that integrate multimodal data, AI algorithms, and biological mechanisms to create predictive and controllable models of cellular behavior [1][4] - A significant study published in the journal Cell established a 4D whole-cell model that accurately simulates the lifecycle of the JCVI-syn3A bacterium, demonstrating the potential of virtual cells in understanding life processes at a molecular level [1][4] Group 1: AI Virtual Cells - AI Virtual Cells are not merely computer simulations but are dynamic digital systems that can replicate real physiological states and predict cellular responses to various interventions [1][4] - The recent research successfully simulated the entire lifecycle of a minimal bacterium, with the cell division process taking 105 minutes, closely matching the actual division time of the bacterium [1][4] Group 2: Applications and Implications - The development of virtual cells provides new tools for understanding how life emerges from molecular interactions, potentially revolutionizing fields such as drug discovery and synthetic biology [4] - The article outlines various applications of AI in biological research, including protein design, antimicrobial peptide design, computer-aided drug design (CADD), and artificial intelligence-driven drug discovery (AIDD) [5][31][34][35] Group 3: Educational Offerings - The article lists several advanced courses related to AI applications in biology, including topics on virtual cell construction, protein design, and synthetic biology, aimed at equipping participants with practical skills and theoretical knowledge [5][31][34][35] - Each course is designed to provide a comprehensive understanding of the respective fields, combining theoretical foundations with hands-on practical sessions [31][34][35] Group 4: Course Benefits and Promotions - The article mentions promotional offers for course registrations, including discounts for multiple course sign-ups and additional benefits such as access to past course recordings and preparatory materials [51][52] - Participants who complete the training and pass the examination can receive a certification that may serve as a valuable credential in their professional development [51]

Conference Overview - The fifth Synbio China conference will be held in Hangzhou on March 31 to April 1, 2026, at the Hilton Garden Inn [7][9] - The conference aims to gather 1,000 participants and is organized by Synbio Deep Wave and Jiangnan University [7][8] Venue and Accommodation - The main venue is the Hilton Garden Inn, located at 600 Jinsada Avenue, Qiantang District, Hangzhou [6][7] - Accommodation options include: - Hilton Garden Inn: 550 RMB per night including breakfast [6] - Holiday Inn: 238 RMB for a double room, excluding breakfast [6] - City Hotel: 238 RMB for a double room, excluding breakfast [6] Transportation - Transportation options to the venue include: - Taxi from Hangzhou East Station: approximately 25 minutes [4] - Metro from Hangzhou East Station: Line 1 to Jinsahu Station, about 30 minutes [4] - Taxi from Hangzhou Xiaoshan International Airport: approximately 40 minutes [4] Agenda Highlights - The conference will feature various sessions, including: - Day 1 AM: Focus on bio-manufacturing industry ecology and functional food science [10] - Day 1 PM: Specialized sessions on food and skincare [10] - Day 2 AM: Focus on functional ingredients and bio-manufacturing innovation [10] - Day 2 PM: Discussions on future food and all-age nutrition [10] Keynote Speakers - Notable speakers include: - An academic from the German Academy of Engineering discussing low-carbon bio-manufacturing technologies [14] - Experts from Jiangnan University and other institutions presenting on various bio-manufacturing topics [15][19] Industry Collaboration - The conference will facilitate networking and collaboration among industry professionals, researchers, and investors [34] - Opportunities for exhibitors and sponsors to showcase their products and services related to synthetic biology and bio-manufacturing [34]

Conference Overview - The Fifth China Synthetic Biology and Biomanufacturing Conference will be held on March 31 to April 1, 2026, at the Heda Hilton Garden Inn in Hangzhou, with an expected attendance of 1,000 participants [5][6]. - The conference is organized by Synbio Deep Wave and co-hosted by Jiangnan University School of Biological Engineering, with support from various media outlets [5]. Venue and Accommodation - The conference will take place at Heda Hilton Garden Inn, located at 600 Jinsada Avenue, Qiantang District, Hangzhou [5]. - Accommodation options include: - Heda Hilton Garden Inn: 550 RMB per night including breakfast [5]. - Holiday Inn Hangzhou Jins Lake: 238 RMB for a double room, 280 RMB for a twin room, excluding breakfast [4]. - Boin City Hotel: 238 RMB for both double and twin rooms, excluding breakfast [4]. Transportation - Transportation options to the venue include: - Taxi from Hangzhou East Station: approximately 25 minutes [5]. - Metro Line 1 from Hangzhou East Station to Jinsahu Station: approximately 30 minutes [5]. - Taxi from Hangzhou Xiaoshan International Airport: approximately 40 minutes [5]. - Bus from Hangzhou Xiaoshan International Airport to Jinsahu Station: approximately 50 minutes [5]. Agenda Highlights - The conference will feature various sessions, including: - "Synthetic Biology Empowering New Materials" by Zhang Kechun, Professor at West Lake University [10]. - "Key Technologies and Applications for Constructing Microbial Cell Factories" by Chen Xiulai, Professor at Jiangnan University [12]. - "Next-Generation Industrial Biotechnology for High-Performance PHA Production" by Lan Yuxuan, Co-founder of Beijing Microstructure Biotechnology Co., Ltd. [14]. - "Industrialization Innovation and Implementation of Starch-Based Biomanufacturing Driven by Synthetic Biology" by Zhou Wenzhi, Founder and CEO of Jiangsu Sanmu Biotechnology Co., Ltd. [20]. Business Cooperation Opportunities - The conference offers exhibition opportunities for companies involved in synthetic biology and modern biotechnology applications, including project roadshows and sponsorship options [22].

Core Viewpoint - The research team led by Professor Chen Xianzhong from Jiangnan University has made significant progress in the degradation of PET plastics, presenting a new integrated self-assembling multi-enzyme display platform for efficient PET waste degradation, published in the Journal of Hazardous Materials [2][3]. Group 1: PET Waste and Environmental Impact - Polyethylene terephthalate (PET) is one of the most widely produced synthetic polyesters, with its waste posing a serious threat to ecosystems due to its difficulty in natural degradation [3]. - The discovery of various PET hydrolases, such as PETase and MHETase, has provided potential for biological degradation of PET, but challenges like poor stability, difficult recovery, and high costs of free enzyme systems hinder large-scale application [3]. Group 2: Research Methodology - The research team utilized Candida tropicalis as a chassis cell, predicting potential GPI-anchored proteins through whole-genome bioinformatics analysis, identifying 22 proteins capable of anchoring foreign proteins to the cell wall [3]. - The team developed an integrated self-assembling multi-enzyme display platform (ISA-MEDP) using SpyTag/SpyCatcher and SnoopTag/SnoopCatcher protein reactions, optimizing the co-display ratio of FAST-PETase and MHETase to create FM series strains [4]. Group 3: Performance Evaluation - The enzyme activity of the best-performing FM2 strain reached 21.34 U/g dry cell weight, with a subsequent increase in enzyme activity by 10.3 times to 220.1 U/g dry cell weight through the use of inducible and repressible promoters [5]. - The ISA-MEDP catalyst demonstrated stability at 45°C for 7 days, maintaining over 50% initial activity after 7 uses, and effectively degrading various untreated post-consumer PET waste into TPA within 7 to 13 days [5]. Group 4: Funding and Acknowledgments - The research was supported by the National Natural Science Foundation and key national research projects, highlighting the importance of funding in advancing biotechnological research [7].

Conference Overview - The Fifth China Synthetic Biology and Biomanufacturing Conference will be held on March 31 to April 1, 2026, at the Heda Hilton Garden Inn in Hangzhou [5][6] - The conference aims to gather around 1,000 participants, focusing on advancements in synthetic biology and biomanufacturing [5] Registration and Participation - Free registration is available, with a limited number of spots, and participants are encouraged to share the event link on social media for additional benefits [3][10] - Attendees must wear their registration badges at all times during the event [5] Transportation and Accommodation - Transportation options include taxi and metro services from Hangzhou East Station and Hangzhou Xiaoshan International Airport to the conference venue [5] - Recommended hotels include Heda Hilton Garden Inn, with room rates starting at 550 CNY per night, and other nearby hotels with varying prices [5] Agenda and Sessions - The conference will feature multiple sessions across two days, including topics such as biomanufacturing industry ecology, functional foods, and innovative projects in biomanufacturing [8][9] - Notable speakers include Zhang Kechun from West Lake University, who will discuss synthetic biology-enabled new materials, and Chen Xiulai from Jiangnan University, focusing on key technologies in microbial cell factory construction [12][15] Business Collaboration Opportunities - The conference offers exhibition spaces for companies involved in synthetic biology and modern biotechnology applications, providing various sponsorship and promotional opportunities [25][26]

Core Viewpoint - The article emphasizes the importance of bio-based chemicals and materials as a key pillar of the bio-manufacturing industry, highlighting their potential to replace traditional petroleum-based products in various sectors such as packaging, textiles, and automotive, driven by global green transformation and carbon neutrality goals [2]. Event Details - The "5th China Synthetic Biology and Bio-Manufacturing Conference" will be held in Hangzhou from March 31 to April 1, 2026, with a focus on bio-based chemicals and materials [3]. - The conference is expected to attract around 1,000 participants and is organized by synbio深波, in collaboration with Jiangnan University [3]. Forum Agenda - The forum will feature a dedicated session on bio-based chemicals and materials, with notable speakers including: - Zhang Kechun, Professor at West Lake University, discussing "Synthetic Biology Empowering New Materials" [6]. - Chen Xiulai, Professor at Jiangnan University, presenting on "Key Technologies and Applications for Microbial Cell Factory Construction" [11]. - Lan Yuxuan, Co-founder of Beijing Microstructure Biotechnology Co., discussing "Next-Generation Industrial Biotechnology for Low-Cost Production of High-Performance PHA" [13]. - Zhou Wenzhi, CEO of Jiangsu Sanmu Biotechnology Co., focusing on "Industrialization Innovation and Implementation of Starch-Based Bio-Manufacturing Driven by Synthetic Biology" [19]. Industry Impact - The conference aims to gather insights from academia, industry, and research to promote high-quality development in the bio-based chemicals and materials sector, which is seen as crucial for the global green transition [2].

Core Insights - The research team led by Professor Liu Liming from Jiangnan University has made significant progress in engineering Corynebacterium glutamicum for the production of 1,5-pentanediamine (PDA), a key monomer for bio-based polyamides, published in Bioresource Technology [2][3] - Traditional chemical synthesis of PDA is associated with high pollution and energy consumption, making microbial fermentation a more sustainable alternative, although high PDA concentrations pose cell toxicity challenges [2] Group 1 - The research identified a previously unreported toxicity cleavage issue during the fermentation process and implemented a dual tolerance engineering strategy [3] - A mutation in the lipoprotein gene cgl1283 (G345D) significantly improved extracellular PDA tolerance, increasing IC₅₀ from 33.5 g/L to 68.9 g/L [3] - Engineering modifications to the CgmA efflux transporter (M284A mutation) reduced intracellular PDA accumulation by 80.7%, alleviating cell toxicity [3] Group 2 - The optimized fermentation process achieved a PDA yield of 130 g/L, a glucose yield of 0.40 g/g, and a production rate of 3.94 g/L/h, all representing the highest reported values for PDA production via fermentation [3] - The study established a comprehensive framework integrating both intracellular and extracellular tolerance engineering, providing effective strategies for microbial production of high-toxicity, high-value chemicals [4] Group 3 - The first author of the paper is master's student Song Longfei, with Professor Liu Liming and Associate Researcher Gao Cong as corresponding authors [5] - The research team has conducted systematic studies in enzyme engineering and the construction of efficient cell factories for high-value compound synthesis, with several original research results published in prestigious journals [5]

Core Insights - The article emphasizes the importance of sustainable materials and green fuels, focusing on biobased and recycled chemicals, materials, and green fuels to tell China's sustainable story [2] Group 1: Project Developments - Shanxi Changqing Biotechnology Co., Ltd. has invested CNY 203 million in a biobased PDO project with an annual production capacity of 15,000 tons, which has recently passed the filing process [5] - The project is a continuation of a successful collaboration between Changqing Biotechnology and Qinghua Zhixing, which previously established a 20,000-ton sugar-based PDO project in 2022 [6] - The new PDO project will utilize existing lysine production facilities, marking a shift towards high-value biobased materials in traditional biomanufacturing [6] Group 2: Market Potential of PDO - 1,3-Propanediol (PDO) is a crucial chemical raw material with applications in cosmetics, food additives, and pharmaceuticals, primarily used as a polymer monomer for producing PTT (polytrimethylene terephthalate), which has a potential market exceeding 5 million tons and a potential value over CNY 100 billion [8] - The current mainstream market price for 1,3-PDO in China ranges from CNY 15,000 to CNY 22,000 per ton, with a target to reduce the price below CNY 15,000 to expand market demand for PTT [26] Group 3: Competitive Landscape - Major players in the biobased PDO market include DuPont and Dow, with Covation LLC being the largest global producer with a capacity of 77,000 tons per year [12][13] - Qinghua Zhixing is noted for its unique dual-pathway PDO fermentation technology, achieving industrial-scale production [17] - Other notable companies include Huaheng Biotechnology, which has established a 50,000-ton PDO production base, and Hengcarbon Technology, which has developed a revolutionary PDO production method with a capacity of 15,000 tons [23][24] Group 4: Industry Trends and Events - The article highlights the upcoming Bio-based 2026 conference in Shanghai, which will focus on the biobased industry, featuring discussions on PDO and PTT, and showcasing various companies in the sector [31][36] - The demand for sustainable materials is shifting from optional to essential for brands, providing a clear demand anchor for the PDO industry chain [27]

Core Viewpoint - The "5th SynBio China Conference on Synthetic Biology and Biomanufacturing" will be held in Hangzhou from March 31 to April 1, 2026, focusing on advancements in synthetic biology and biomanufacturing [2][8]. Group 1: Conference Details - The conference will feature a special session on bio-based chemicals and materials, with Professor Chen Xiulai from Jiangnan University presenting on "Key Technologies and Applications for Microbial Cell Factory Construction" [2][8]. - The event is expected to attract around 1,000 participants and is organized by SynBio Deep Wave in collaboration with Jiangnan University [8]. - Various sessions will cover topics such as biomanufacturing industry ecology, functional food and nutrition science, and applications of biomanufacturing technology [9]. Group 2: Research Contributions - Professor Chen Xiulai's research addresses critical issues in microbial chemical synthesis, including low flux, high dispersion, and slow rates, by developing new strategies for enhancing metabolic flow and controlling cell lifespan [4][5]. - The research has led to significant economic and social benefits by improving the production of organic acids, amino acids, and other multi-carbon chemicals, addressing industry challenges such as low yields and long fermentation cycles [5]. Group 3: Agenda Highlights - The agenda includes presentations on various topics, such as the construction of microbial cell factories, low-cost production of high-performance PHA, and the development of bio-based materials [13]. - Notable speakers include Zhang Kechun from Westlake University and other industry leaders, discussing innovations in synthetic biology and biomanufacturing [13]. Group 4: Participation and Collaboration - The conference offers opportunities for exhibitors from synthetic biology and modern biotechnology sectors, providing a platform for showcasing technologies and products [16]. - Free registration is available for attendees, with limited spots, emphasizing the importance of early registration [19].